Mgo One Seven LLC Argenx Se Transaction History
Mgo One Seven LLC
- $4.05 Billion
- Q3 2025
A detailed history of Mgo One Seven LLC transactions in Argenx Se stock. As of the latest transaction made, Mgo One Seven LLC holds 579 shares of ARGX stock, worth $525,720. This represents 0.01% of its overall portfolio holdings.
Number of Shares
579
Previous 381
51.97%
Holding current value
$525,720
Previous $210,000
103.33%
% of portfolio
0.01%
Previous 0.01%
Shares
8 transactions
Others Institutions Holding ARGX
# of Institutions
525Shares Held
26MCall Options Held
589KPut Options Held
320K-
Price T Rowe Associates Inc Baltimore, MD3.64MShares$3.31 Billion0.29% of portfolio
-
Janus Henderson Group PLC London, X02.58MShares$2.34 Billion0.92% of portfolio
-
Artisan Partners Limited Partnership Milwaukee, WI2.19MShares$1.99 Billion2.46% of portfolio
-
Capital World Investors Los Angeles, CA1.96MShares$1.78 Billion0.21% of portfolio
-
Black Rock Inc. New York, NY1.01MShares$918 Million0.01% of portfolio
About ARGENX SE
- Ticker ARGX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 55,323,800
- Market Cap $50.2B
- Description
- argenx SE, a biotechnology company, focuses on developing various therapies for the treatment of autoimmune diseases in the United States, the Netherlands, Belgium, Japan, Switzerland, Germany and France. Its lead product candidate is efgartigimod for the treatment of patients with myasthenia gravis, immune thrombocytopenia, pemphigus vulgaris, ...